Locally Advanced Cervical Carcinoma, Surgery, Therapy, Uterine Cervical Neoplasms
Conditions
Keywords
Uterine Cervical Neoplasms, cervical cancer, Gastric - type Mucinous Adenocarcinoma, surgery
Brief summary
This study aims to collect data of patients with Gastric-type Endocervical Adenocarcinoma from the SEER database, analyze the related prognostic factors and treatment patterns of Gastric-type Endocervical Adenocarcinoma, and explore the impact of surgical treatment on the prognosis of locally advanced Gastric-type Endocervical Adenocarcinoma.
Detailed description
This study aims to collect data of patients with Gastric - type Endocervical Adenocarcinoma from the SEER database, analyze the related prognostic factors and treatment patterns of patients with Gastric - type Endocervical Adenocarcinoma, and explore the impact of surgical treatment on the prognosis of locally advanced Gastric - type Endocervical Adenocarcinoma. Study subjects: Patients diagnosed with Gastric - type Endocervical Adenocarcinoma were identified using the SEER database and SEER\*Stat 8.4.2 software. The search scope was the SEER Research Plus Data, 17 Registries, Nov 2021 sub (2000 - 2019) database, and the screening criteria included Site and Morphology, Analytic Behavior Recode = Malignant and Site and Morphology, ICD - O - 3 / WHO 2008 Recode Site = Cervix. Patients with cervical Gastric - type Endocervical Adenocarcinoma were selected from the database. Outcome measures: Overall survival (OS): The time from diagnosis to death of the patient.
Interventions
PROCEDUREsurgery
The patient underwent surgery.
Sponsors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with Gastric - type Endocervical Adenocarcinoma were identified using the SEER database and SEER\*Stat 8.4.2 software. The search scope was the SEER Research Plus Data, 17 Registries, Nov 2021 sub (2000 - 2019) database. The screening criteria included Site and Morphology, Analytic Behavior Recode = Malignant and Site and Morphology, ICD - O - 3 / WHO 2008 Recode Site = Cervix. Patients with Gastric - type Endocervical Adenocarcinoma in the database were selected.
Exclusion criteria
* Patients with a survival time of 0 or unknown.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall survival (OS) | The time from diagnosis to death of the patient，Assessed up to 227 months | The time from diagnosis to death of the patient. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Vital status recode(study cutoff used) | up to 227 months | Any patient that dies after the follow-up cut-off date is recoded to alive as of the cut-off date. |
Countries
China
Outcome results
None listed